Top Markets
#1 Black Phoenix Black Phoenix +367.56%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.03%
#5 Akedo Akedo +41.87%
#6 Acurast Acurast +35.56%
#7 BasedHype BasedHype +29.98%
#8 GoPlus Security GoPlus Security +22.00%
#9 Cryptopia Cryptopia +21.42%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +21.15%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rank in Stocks #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Share Price
$0.0202
Last synced: 2024-11-19
Market Cap
$44.67K
Change (1 day)
-0.49%
Change (1 year)
0.00%
Country
IL
Trade Notable Labs, Ltd. (NTBL)

Category

Healthcare
P/B ratio for Notable Labs, Ltd. (NTBL)
P/B ratio as of August 2026 TTM: 0.04
According to Notable Labs, Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0.04. At the end of 2022 the company had a P/B ratio of -0.25.
P/B ratio history for Notable Labs, Ltd. from 2015 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 0.04 -86.41%
2023 0.27 -208.34%
2022 -0.25 -99.73%
2021 -93.37 -186.36%
2020 108.12 83.51%
2019 58.92 179.46%
2018 21.08 -82.69%
2017 121.80 21.83%
2016 99.97 -6.40%
2015 106.81 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 16,960.76%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 17,197.82%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 9,801.91%
BE